Selenium sulfide

DERMATOLOGICALS

Key facts

Selenium sulfide is an ofp drug catalogued in DrugCentral. It was first approved by the FDA in 1951. Recorded indications include Pityriasis simplex, Pityriasis versicolor and Seborrheic dermatitis.

• Approval status: ofp (first approved 1951 by the FDA).
• Indications: Pityriasis simplex, Pityriasis versicolor and Seborrheic dermatitis.
• ATC code: D01AE13 (Other antifungals for topical use).
• Molecular formula: S2Se; molecular weight 143.09 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (3)

• Pityriasis simplex
• Pityriasis versicolor
• Seborrheic dermatitis

Contraindications (2)

• Distinctive exudative discoid AND lichenoid chronic dermatosis of Sulzberger and Garbe
• Inflammatory dermatosis

Regulatory approvals (1)

Date	Agency	Marketed as	Applicant	Orphan
1951-05-17	FDA	—	CHATTEM

ATC classification

ATC code	Therapeutic hierarchy
D01AE13	DERMATOLOGICALS › ANTIFUNGALS FOR DERMATOLOGICAL USE › ANTIFUNGALS FOR TOPICAL USE › Other antifungals for topical use

Reported adverse-event signals

Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.

MedDRA term	LLR
Lactobacillus test positive	25.8

Chemical structure

• Molecular formula: S₂Se
• Molecular weight: 143.09 g/mol
• CAS number: —
• InChIKey: JNMWHTHYDQTDQZ-UHFFFAOYSA-N
• PubChem CID: 24011

S=[Se]=S

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Selenium sulfide used for?

DrugCentral lists the following indications for Selenium sulfide: Pityriasis simplex, Pityriasis versicolor and Seborrheic dermatitis.

When was Selenium sulfide first approved?

Selenium sulfide was first approved by the FDA in 1951.

What is the chemical formula of Selenium sulfide?

Selenium sulfide has the molecular formula S2Se and a molecular weight of 143.09 g/mol.

Sources

• DrugCentral drug card 4274 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
• ChEMBL CHEMBL1200680 — compound record and bioactivity
• PubChem CID 24011 — chemical identifiers
• DrugBank DB00971 — drug record
• FDA UNII Z69D9E381Q — substance identity
• DailyMed: FDA labels for Selenium sulfide — current prescribing information (label search)
• FDA Adverse Event Reporting System (openFDA FAERS) — adverse-event signals, as aggregated by DrugCentral

How this page is built: methodology · editorial policy & corrections.